Long-term response rates of successful hepatitis B vaccination in HIV-infected patients
Authors:
- Vania Baptista LopesVLVania Baptista Lopes
- Robert J. HassingRHRobert J. Hassing
- Theodora E.M.S. de Vries-SluijsTVTheodora E.M.S. de Vries-Sluijs
- Abdel el BarzouhiABAbdel el Barzouhi
- Bettina E. HansenBHBettina E. Hansen
- Martin SchuttenMSMartin Schutten
- Robert A. de ManRMRobert A. de Man
- Marchina E. van der EndeMEMarchina E. van der Ende
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapyVaccine, 2011
- A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive PatientsThe Journal of Infectious Diseases, 2011
- Efficacy of Double-Dose Hepatitis B Rescue Vaccination in HIV-Infected PatientsAIDS Patient Care and STDs, 2010
- Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster DoseThe Journal of Infectious Diseases, 2009
- Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patientsVaccine, 2009
- CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 YearsClinical Infectious Diseases, 2008
- Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutantsVaccine, 2005
- Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workersVaccine, 2004
- Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral loadVaccine, 2000
- Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year resultsVaccine, 1998